SABINA INTERNATIONAL
Study identifier:D589SR00002
ClinicalTrials.gov identifier:NCT03857178
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Multi-country study on the Prescription Patterns of Short Acting Beta-2 Agonist (SABA) and its potential effects on asthma control: A Cross-Sectional Study on SABA use in Asthma
Medical condition
asthma
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
8617
Study type
Observational
Age
N/A
Date
Study Start Date: 29 Mar 2019
Primary Completion Date: 06 May 2020
Study Completion Date: 06 May 2020
Study design
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2021 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
